SHAJEEN AKTHER: Open Payments
NPI 1952072555 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 37 payments from 13 companies in 2025. Trend: 2023 $1,209 · 2024 $1,099 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $110 |
| GENZYME CORPORATION | 3 | $97 |
| Organon LLC | 6 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| UCB, Inc. | 2 | $78 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Galderma Laboratories, L.P. | 2 | $40 |
| LEO Pharma Inc. | 1 | $31 |
Products named: DUPIXENT, RINVOQ, COSENTYX, Bimzelx, Sotyktu, ILUMYA, Winlevi, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
